2019 SFAR指南:术后疼痛管理

2019-02-26 法国麻醉和重症医学学会 Anaesth Crit Care Pain Med. 2019 Feb 26.

2019年2月,法国麻醉和重症医学学会(SFAR)更新发布了术后疼痛管理指南,该指南时对2008年版指南的更新,指南主要内容涉及围术期疼痛评估,镇痛检查,术后疼痛药物治疗和术后局部镇痛。

中文标题:

2019 SFAR指南:术后疼痛管理

英文标题:

Revision of Expert Panel''s Guidelines on Postoperative Pain Management.

发布日期:

2019-02-26

简要介绍:

2019年2月,法国麻醉和重症医学学会(SFAR)更新发布了术后疼痛管理指南,该指南时对2008年版指南的更新,指南主要内容涉及围术期疼痛评估,镇痛检查,术后疼痛药物治疗和术后局部镇痛。 

拓展指南:疼痛相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 SFAR指南:术后疼痛管理)] GetToolGuiderByIdResponse(projectId=1, id=506e11c001e1667d, title=2019 SFAR指南:术后疼痛管理, enTitle=Revision of Expert Panel''s Guidelines on Postoperative Pain Management., guiderFrom=Anaesth Crit Care Pain Med. 2019 Feb 26., authorId=null, author=, summary=2019年2月,法国麻醉和重症医学学会(SFAR)更新发布了术后疼痛管理指南,该指南时对2008年版指南的更新,指南主要内容涉及围术期疼痛评估,镇痛检查,术后疼痛药物治疗和术后局部镇痛。 , cover=, journalId=null, articlesId=null, associationId=806, associationName=法国麻醉和重症医学学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Feb 26 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年2月,法国麻醉和重症医学学会(SFAR)更新发布了术后疼痛管理指南,该指南时对2008年版指南的更新,指南主要内容涉及围术期疼痛评估,镇痛检查,术后疼痛药物治疗和术后局部镇痛。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>疼痛</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=cccc61c001e0725b" title="2018 ACR适宜性标准:右下腹疼痛——疑似阑尾炎" target=_blank>2018 ACR适宜性标准:右下腹疼痛——疑似阑尾炎</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=043371c001e0063d" title="临床药师术后疼痛管理指引" target=_blank>临床药师术后疼痛管理指引</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0eccd1c0016960c6" title="2018 ACR适宜性标准:绝经后亚急性或慢性盆腔疼痛" target=_blank>2018 ACR适宜性标准:绝经后亚急性或慢性盆腔疼痛</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5e7151c0016859e9" title="慢性肌肉骨骼疼痛的药物治疗专家共识(2018)" target=_blank>慢性肌肉骨骼疼痛的药物治疗专家共识(2018)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c58601c0016e119b" title="2018 EFIC意见书:癌症相关疼痛管理标准" target=_blank>2018 EFIC意见书:癌症相关疼痛管理标准</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%96%BC%E7%97%9B" target=_blank>有关疼痛更多指南</a></ul>, tagList=[TagDto(tagId=25605, tagName=术后疼痛)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=17293, appHits=601, showAppHits=2, pcHits=8290, showPcHits=10656, likes=107, shares=37, comments=4, approvalStatus=1, publishedTime=Sun Mar 24 11:53:27 CST 2019, publishedTimeString=2019-02-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 24 11:53:27 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 18:57:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 SFAR指南:术后疼痛管理)])
2019 SFAR指南:术后疼痛管理
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1007911, encodeId=ae66100e9118c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f7c9165d67749b6bb00db77ded1ff54/0f86a7b6d3104bd1b0c32e6f8987dbc8.jpg, createdBy=ad2e5572973, createdName=ms6000002127463854, createdTime=Sat Aug 14 21:04:53 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922699, encodeId=8bf6922699d2, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=960d5455587, createdName=ms3000000711267757, createdTime=Thu Feb 04 07:58:51 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363676, encodeId=31e63636e619, content=很有帮助,谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d11348178, createdName=yangcaom, createdTime=Thu Mar 28 07:08:28 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
    2021-08-14 ms6000002127463854

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1007911, encodeId=ae66100e9118c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f7c9165d67749b6bb00db77ded1ff54/0f86a7b6d3104bd1b0c32e6f8987dbc8.jpg, createdBy=ad2e5572973, createdName=ms6000002127463854, createdTime=Sat Aug 14 21:04:53 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922699, encodeId=8bf6922699d2, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=960d5455587, createdName=ms3000000711267757, createdTime=Thu Feb 04 07:58:51 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363676, encodeId=31e63636e619, content=很有帮助,谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d11348178, createdName=yangcaom, createdTime=Thu Mar 28 07:08:28 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
    2021-02-04 ms3000000711267757

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1007911, encodeId=ae66100e9118c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f7c9165d67749b6bb00db77ded1ff54/0f86a7b6d3104bd1b0c32e6f8987dbc8.jpg, createdBy=ad2e5572973, createdName=ms6000002127463854, createdTime=Sat Aug 14 21:04:53 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922699, encodeId=8bf6922699d2, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=960d5455587, createdName=ms3000000711267757, createdTime=Thu Feb 04 07:58:51 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363676, encodeId=31e63636e619, content=很有帮助,谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d11348178, createdName=yangcaom, createdTime=Thu Mar 28 07:08:28 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
    2019-03-28 yangcaom

    很有帮助,谢谢分享!

    0